DK1803447T3 - Farmaceutisk sammensætning til vedvarende frisætning af hydralazin og anvendelse heraf som en understötning for cancerbehandling - Google Patents
Farmaceutisk sammensætning til vedvarende frisætning af hydralazin og anvendelse heraf som en understötning for cancerbehandlingInfo
- Publication number
- DK1803447T3 DK1803447T3 DK04774809T DK04774809T DK1803447T3 DK 1803447 T3 DK1803447 T3 DK 1803447T3 DK 04774809 T DK04774809 T DK 04774809T DK 04774809 T DK04774809 T DK 04774809T DK 1803447 T3 DK1803447 T3 DK 1803447T3
- Authority
- DK
- Denmark
- Prior art keywords
- hydralazine
- support
- pharmaceutical composition
- sustained release
- cancer treatment
- Prior art date
Links
- RPTUSVTUFVMDQK-UHFFFAOYSA-N Hidralazin Chemical compound C1=CC=C2C(NN)=NN=CC2=C1 RPTUSVTUFVMDQK-UHFFFAOYSA-N 0.000 title 2
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 229960002474 hydralazine Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000013268 sustained release Methods 0.000 title 1
- 239000012730 sustained-release form Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/MX2004/000064 WO2006028362A1 (es) | 2004-09-09 | 2004-09-09 | Composición farmacéutica de liberación prolongada de hidralazina y su uso como apoyo para el tratamiento del cáncer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1803447T3 true DK1803447T3 (da) | 2009-10-12 |
Family
ID=36036613
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04774809T DK1803447T3 (da) | 2004-09-09 | 2004-09-09 | Farmaceutisk sammensætning til vedvarende frisætning af hydralazin og anvendelse heraf som en understötning for cancerbehandling |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7820200B2 (da) |
| EP (1) | EP1803447B1 (da) |
| JP (1) | JP4814885B2 (da) |
| CN (1) | CN101039661A (da) |
| BR (1) | BRPI0419032B8 (da) |
| CA (1) | CA2579220C (da) |
| CR (1) | CR9035A (da) |
| CY (1) | CY1110508T1 (da) |
| DE (1) | DE602004022205D1 (da) |
| DK (1) | DK1803447T3 (da) |
| ES (1) | ES2330227T3 (da) |
| MX (1) | MX2007002871A (da) |
| NZ (1) | NZ554360A (da) |
| PL (1) | PL1803447T3 (da) |
| PT (1) | PT1803447E (da) |
| SI (1) | SI1803447T1 (da) |
| WO (1) | WO2006028362A1 (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201618783A (zh) | 2014-08-07 | 2016-06-01 | 艾森塔製藥公司 | 以布魯頓(Bruton)氏酪胺酸激酶(BTK)佔據和BTK再合成速率為基礎之治療癌症、免疫和自體免疫疾病及發炎性疾病之方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK150008C (da) | 1981-11-20 | 1987-05-25 | Benzon As Alfred | Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat |
| US4521402A (en) * | 1983-01-03 | 1985-06-04 | Verex Laboratories, Inc. | Constant release rate solid oral dosage formulations of hydrazine |
| US4461759A (en) * | 1983-01-03 | 1984-07-24 | Verex Laboratories, Inc. | Constant release rate solid oral dosage formulations of veropamil |
| IE58110B1 (en) | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
| GB8624213D0 (en) * | 1986-10-09 | 1986-11-12 | Sandoz Canada Inc | Sustained release pharmaceutical compositions |
| EP1169024B1 (en) * | 1999-03-31 | 2005-12-21 | Janssen Pharmaceutica N.V. | Pregelatinized starch in a controlled release formulation |
| US20030091630A1 (en) * | 2001-10-25 | 2003-05-15 | Jenny Louie-Helm | Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data |
| US20050226926A1 (en) * | 2002-07-25 | 2005-10-13 | Pfizer Inc | Sustained-release tablet composition of pramipexole |
| AU2003301654A1 (en) * | 2002-10-22 | 2004-05-13 | Dainippon Pharmaceutical Co., Ltd. | Stabilized composition |
-
2004
- 2004-09-09 DE DE602004022205T patent/DE602004022205D1/de not_active Expired - Lifetime
- 2004-09-09 BR BRPI0419032A patent/BRPI0419032B8/pt not_active IP Right Cessation
- 2004-09-09 JP JP2007531093A patent/JP4814885B2/ja not_active Expired - Lifetime
- 2004-09-09 EP EP04774809A patent/EP1803447B1/en not_active Expired - Lifetime
- 2004-09-09 DK DK04774809T patent/DK1803447T3/da active
- 2004-09-09 SI SI200431198T patent/SI1803447T1/sl unknown
- 2004-09-09 ES ES04774809T patent/ES2330227T3/es not_active Expired - Lifetime
- 2004-09-09 PL PL04774809T patent/PL1803447T3/pl unknown
- 2004-09-09 CN CNA2004800439530A patent/CN101039661A/zh active Pending
- 2004-09-09 US US11/575,016 patent/US7820200B2/en not_active Expired - Lifetime
- 2004-09-09 PT PT04774809T patent/PT1803447E/pt unknown
- 2004-09-09 WO PCT/MX2004/000064 patent/WO2006028362A1/es not_active Ceased
- 2004-09-09 CA CA2579220A patent/CA2579220C/en not_active Expired - Lifetime
- 2004-09-09 NZ NZ554360A patent/NZ554360A/en not_active IP Right Cessation
-
2007
- 2007-03-09 MX MX2007002871A patent/MX2007002871A/es active IP Right Grant
- 2007-04-09 CR CR9035A patent/CR9035A/es not_active Application Discontinuation
-
2009
- 2009-10-13 CY CY20091101053T patent/CY1110508T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2579220C (en) | 2013-01-08 |
| SI1803447T1 (sl) | 2010-01-29 |
| BRPI0419032B1 (pt) | 2019-02-05 |
| CA2579220A1 (en) | 2006-03-16 |
| JP2008512450A (ja) | 2008-04-24 |
| BRPI0419032A (pt) | 2007-12-11 |
| EP1803447A1 (en) | 2007-07-04 |
| CY1110508T1 (el) | 2015-04-29 |
| NZ554360A (en) | 2009-11-27 |
| MX2007002871A (es) | 2007-04-23 |
| PT1803447E (pt) | 2009-08-14 |
| BRPI0419032B8 (pt) | 2021-05-25 |
| US20090042889A1 (en) | 2009-02-12 |
| CN101039661A (zh) | 2007-09-19 |
| WO2006028362A1 (es) | 2006-03-16 |
| EP1803447B1 (en) | 2009-07-22 |
| PL1803447T3 (pl) | 2010-05-31 |
| DE602004022205D1 (de) | 2009-09-03 |
| JP4814885B2 (ja) | 2011-11-16 |
| ES2330227T3 (es) | 2009-12-07 |
| US7820200B2 (en) | 2010-10-26 |
| CR9035A (es) | 2009-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2013035I1 (el) | Μεθοδοι χρησης συνθεσεων αμινοπυριδινης παρατεταμενης αποδεσμευσης | |
| DK1856374T3 (da) | Sammensætning og fremgangsmåde til fremstilling af et støttemiddel | |
| DK1824475T3 (da) | Fremgangsmåde til oprensning af trans-(-)-delta9-tetrahydrocannabinol og trans-(+)-delta9-tetrahydrocannabinol | |
| DK1913001T3 (da) | (r)-n-methylnaltrexon, fremgangsmåder til syntese og farmaceutisk anvendelse heraf | |
| DK1940364T3 (da) | Kapselformulering af pirfenidon og farmaceutisk acceptable excipienser | |
| DK1830838T3 (da) | Sammensætninger og fremgangsmåder til behandling af neoplastiske sygdomme | |
| DK1888595T3 (da) | Spiro-oxindolforbindelser og deres anvendelser som terapeutiske midler | |
| DK1805312T3 (da) | Fremgangsmåder og midler til fremstilling af hyaluronan | |
| DK2220116T3 (da) | Sammensætninger og fremgangsmåder til terapien og diagnosticeringen af influenza | |
| DK3719018T3 (da) | Purin og deazapurinderivater som farmaceutiske forbindelser | |
| DK2058020T3 (da) | Indretning til indgivelse af lægemiddel | |
| DK1868579T3 (da) | Farmaceutisk sammensætning omfattende en omega-carboxyaryl sunstitueret diphenylurea til behandling af cancer | |
| DK3081215T3 (da) | Sammensætninger og fremgangsmåder til langvarig frigørelse af beta-alanin | |
| DK1898829T3 (da) | Fremgangsmåde til fremstilling af en tandprotesedel og således fremstillet tandprotesedel | |
| DK1771201T3 (da) | Sammensætninger og fremgangsmåder til behandling eller forebyggelse af oxalat-relateret sygdom | |
| IS8597A (is) | Samsetningar rísedrónats og aðferðir við notkun þess | |
| DK1781256T3 (da) | Phospholipid-gel-sammensætning til lægemiddelafgivelse og fremgangsmåder til behandling af sygdomme ved hjælp af samme | |
| DK2063881T3 (da) | Sammensætning og fremgangsmåde til virksom og sikker administration af halopyruvat til behandlingen af cancer | |
| DK1701698T3 (da) | Direkte komprimerbart farmaceutisk præparat til oral indgivelse af CCI-779 | |
| DK2043671T3 (da) | Peptid og sammensætning deraf til anvendelse ved behandling af slagtilfælde med feber | |
| DK3072507T3 (da) | Farmaceutiske sammensætninger til glukokortikoidsubstitutionsterapi | |
| DK1774566T3 (da) | Sammensætninger til afgivelse af kviksölv og fremgangsmåde til fremstilling deraf | |
| DK1862158T3 (da) | Farmaceutisk sammensætning til behandling af depression og fremgangsmåde til fremstilling deraf | |
| DK2004295T3 (da) | Sammensætning til brandbekæmpelse og formulering af nævnte sammensætning | |
| DK2158194T3 (da) | Derivater af 7-alkynyl-1,8-naphtyridoner, fremgangsmåde til fremstilling deraf og terapeutisk anvendelse deraf |